Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Infection > Candedmia > Flashcards

Candedmia Flashcards

1
Q

Candidiasis

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

primary or secondary mycotic disease caused by a
member of the genus Candida.

A

U

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

clinical manifestations may be acute,
subacute or chronic.

A

H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Involvement may be localized to the mouth, throat, skin,
vagina, fingers, nails, bronchii, lungs or the gastrointestinal tract, or become
systemic following candidemia.

A

K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Occurrence

A

Y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Part of naturally occurring microbial flora -skin, body orifices,
gastrointestinal tract.

A

H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mostly endogenous in origin

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Epidemiology

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The third most common pathogen isolated from blood in critically ill
patients.

A

K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

being the most common causative species.

A

H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The major causative species are:

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Candida albicans (> 50%)

A

K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

parapsilosis

A

I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

dubliniensis

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

tropicalis

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

krusei

A

K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

glabrata

A

U

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

auris

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

emerging fungus that presents a serious global
health threat.

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Often multidrug-resistant yeast that can cause a wide spectrum of
infections.

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Issues related to detection methods

A

U

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Propensity to cause outbreaks in healthcare setting

A

U

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HOW TO IDENTIFYING PATIENTS AT RISK OF CANDIDEMIA ?

A

H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ICU and Surgical patients

A

K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Immunocompromised patients

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Central venous catheter

A

P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Hematological malignancy

A

I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

TPN

A

*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Solid organ transplantation

A

I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Broad spectrum antibiotics

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Hematopoietic stem cell transplantation

A

N

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Acute Renal failure

A

O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Chemotherapy

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Recent surgery

A

O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Steroids

A

K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

GI perforation and leaks

A

O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Prolonged Neutropenia

A

H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Colonization by Candida spp.

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

High APACHE score

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Risk factor
Candida glabrata

A

I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Candida parapsilosis
RF

A

F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Candida tropicalis
RF

A

F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Candida krusei
RF

A

O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Candida auris
RF

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Elderly

A

G

46
Q

Malignancy & solid organ Tx

A

G

47
Q

Antifungal exposure

A

G

48
Q

TPN & CVC

A

T

49
Q

Nosocomial outbreak (biofilms) >children

A

G

50
Q

Hematological malignancies and neutropenia

A

G

51
Q

GI surgery

A

H

52
Q

Fluconazole exposure

A

T

53
Q

Immunosuppression

A

T

54
Q

Exposure to antifungal therapy

A

G

55
Q

Broad spectrum antibiotics

A

G

56
Q

Nosocomial outbreak (biofilms)

A

T

57
Q

Vascular surgery

A

T

58
Q

Diagnoses of candidemia

A

D

59
Q

Blood culture

A

D

60
Q

Immunological Assays

A

D

61
Q

Nucleic acid amplification-based tests

A

D

62
Q

T2Candida

A

(

63
Q

glucan

A

F

64
Q

Mannan

A

F

65
Q

real-time PCR assays

A

D

66
Q

three to five hours

A

D

67
Q

detection of bloodstream infection caused by 5 candida species.

A

E

68
Q

The assay breaks yeast cells apart, releasing DNA; copies the target DNA; and
detects the amplified DNA using magnetic resonance technology.

A

D

69
Q

Empirical treatment

A

E

70
Q

Preemptive treatment

A

D

71
Q

Definitive

A

F

72
Q

Prophylaxis

A

F

73
Q

defined as antibacterial treatment of patients who have
persistent or recurrent fever.

A

F

74
Q

was defined as treatment of patients who have clinical, imaging, or
galactomannan-antigen-assay evidence suggesting fungal disease

A

R

75
Q

treatment plan for a disease or disorder that has been chosen as the best
one for a patient after all other choices have been considered of which there is supportive
diagnostic and clinical results .

A

F

76
Q

treatment given or action taken to prevent disease.

A

F

77
Q

Candida score

A

S

78
Q

Severe sepsis

A

B

79
Q

Multifocal Candida

A

F

80
Q

Surgery

A

D

81
Q

2 point

A

V

82
Q

1 point

A

F

83
Q

candida score’ of > 3 was classed as a positive ‘candida score’ which should identify patients who would benefit from early antifungal treatment

A

F

84
Q

Classes of Antifungals

A

F

85
Q

Polyenes

A

E

86
Q

Azoles

A

C

87
Q

Echinocandins

A

R

88
Q

Amphotericin B

A

F

89
Q

Abelcet

A

G

90
Q

Ambisome

A

F

91
Q

Caspofungin

A

F

92
Q

Micafungin

A

F

93
Q

Anidulafungin

A

G

94
Q

bind with sterols in the fungal cell membrane, principally ergosterol. This causes the cell’s contents to leak out and the cell dies. Animal cells contain cholesterol instead of ergosterol and so they are much less susceptible.

A

F

95
Q

Inhibit the enzyme cytochrome P450 14α-demethylase. This enzyme converts
lanosterol to ergosterol and is required in fungal cell membrane synthesis.

A

I

96
Q

inhibit the synthesis of glucan in the cell wall,
probably via the enzyme 1,3-β glucan synthase:

A

Y

97
Q

Guidelines for treatment IDSA

A

J

98
Q

Neutropenic

A

D

99
Q

Non Neutropenic

A

D

100
Q

Lipid formulation Amphotericin B

A

F

101
Q

Voriconazole

A

U

102
Q

mould

A

D

103
Q

Second choice

A

D

104
Q

Step down

A

D

105
Q

Third choice

A

D

106
Q

Loading dose 70 mg then 50 mg

A

V

107
Q

Loading dose 800 mg then 400 mg

A

C

108
Q

0.5-0.7 mg/kg/daily

A

V

109
Q

3-5 mg/kg

A

C

110
Q

Loading dose 400 followed by 200-300

A

D

Infection (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions